US Stock MarketDetailed Quotes

VRCA Verrica Pharmaceuticals

Watchlist
  • 0.798
  • -0.633-44.23%
Close Nov 5 16:00 ET
  • 0.808
  • +0.010+1.27%
Pre 09:05 ET
36.37MMarket Cap-433P/E (TTM)

Verrica Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Verrica Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 335.000K--
--2024/Q3-1.781M / 5.262M--
Aug 14, 20242024/Q25.177M / 4.550M--
May 13, 20242024/Q13.826M / 2.651M--
Feb 29, 20242023/Q41.988M / 948.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 335.000K--
--2024/Q3-1.781M / 5.262M--
Aug 14, 20242024/Q25.177M / 4.550M--
May 13, 20242024/Q13.826M / 2.651M--
Feb 29, 20242023/Q41.988M / 948.000K--

Unlock Free Earnings Estimates

Verrica Pharmaceuticals Earnings Reports

  • Verrica Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    11:58 ET

  • Verrica Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 14 08:09 ET

  • Verrica Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 13 08:04 ET

  • Verrica Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 29 08:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Hold

    • Buy

      20.00%

    • Hold

      80.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data